Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer
Author: Ponnusamy, S.
Coss, C.
Thiyagarajan, T.
Watts, K.
Hwang, D.-J.
He, Y.
Selth, L.
McEwan, I.
Duke, C.
Pagadala, J.
Singh, G.
Wake, R.
Ledbetter, C.
Tilley, W.
Moldoveanu, T.
Dalton, J.
Miller, D.
Narayanan, R.
Citation: Cancer Research, 2017; 77(22):6282-6298
Publisher: American Association for Cancer Research
Issue Date: 2017
ISSN: 0008-5472
Statement of
Suriyan Ponnusamy, Christopher C. Coss, Thirumagal Thiyagarajan, Kate Watts, Dong-Jin Hwang, Yali He, Luke A. Selth, Iain J. McEwan, Charles B. Duke, Jayaprakash Pagadala, Geetika Singh, Robert W. Wake, Christopher Ledbetter, Wayne D. Tilley, Tudor Moldoveanu, James T. Dalton, Duane D. Miller and Ramesh Narayanan
Abstract: Abstract not available
Keywords: Cell Line, Tumor
Mice, Inbred NOD
Mice, Knockout
Mice, SCID
Receptors, Androgen
Xenograft Model Antitumor Assays
Gene Expression Profiling
Cell Proliferation
Gene Expression Regulation, Neoplastic
Alternative Splicing
Molecular Structure
Androgen Receptor Antagonists
Prostatic Neoplasms, Castration-Resistant
Rights: © 2017 American Association for Cancer Research.
DOI: 10.1158/0008-5472.can-17-0976
Appears in Collections:Aurora harvest 8
Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.